India’s Dr. Reddy’s Laboratories is partnering Israel’s Edity Therapeutics (see here previously). They plan to build a platform for developing intracellular proteins to destroy solid tumors. https://www.webwire.com/ViewPressRel.asp?aId=316507

Israel’s Edity Therapeutics reprograms immune cells to recognize tumors that hide from the body’s regular immune system. Edity’s ED 007 cell therapy inflames these tumors, triggering the body’s own immune system to kill the cancer without risk of side effects … Continue reading →